Methods for subtyping diffuse large B-cell lymphoma (DLBCL)
US11384399B2 · kind B2 · utility
0Cited by
1References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 29, 2016 |
| Grant date | Jul 12, 2022 |
| Priority date | — |
| Expiry date | Mar 11, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Described herein are innovations for classifying subtypes of DLBCL, as well as using the results of classification for diagnosis, prognosis, and therapy selection. In this way, the classifier can effectively classify subtypes of DLBCL and provide meaningful output for the benefit of medical practices and DLBCL patients. Also described are arrays and kits that can be used to measure expression of DLBCL signatures genes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.